CNTB 10-Q: SEC filing

Connect Biopharma Holdings Ltd

Filed with the SEC on · accession 0001835268-26-000047

CNTB filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -5.1% by the first close after the filing.

Summary of the filing

Connect Biopharma Holdings Ltd filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures.

Key details

FilerConnect Biopharma Holdings Ltd

How CNTB stock reacted

Close before

$0.68

Nov 13, 2026

First close after

-5.05%

$0.64

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for CNTB, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CNTB?

Click here

Frequently asked questions

What did CNTB file with the SEC on Nov 16, 2026?

CNTB filed a 10-Q (SEC filing). Connect Biopharma Holdings Ltd filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did CNTB stock react to this filing?

CNTB closed at $0.68 before the filing and $0.64 on Nov 16, 2026 (-5.05%).

Other CNTB SEC filings

Get alerts when CNTB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days